Although a clearly defined set of surface markers remains to delineate cytotoxic CD4+ T cells from other CD4+ T cell subsets, there is a growing interest in the role of this cytotoxic subset in fighting infectious diseases, promoting autoimmunity, and eliminating cancers. The gene discussed is CD4; the disease is cancer.